{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-201351","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.438130+00:00","generated_at":"2026-05-17T06:52:52.927905+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Jaguar Health raises $2.38M via Series N Perpetual Preferred Stock PIPE","bullets":["Issued ~951 Series N Preferred shares at $2,500 stated value each for aggregate proceeds of $2.38M.","Series N Preferred non-dividend, non-convertible but exchangeable into common at $1.20 per share after shareholder approval.","Proceeds to be used for working capital and repayment of certain existing notes.","Company must seek stockholder approval within 90 days; beneficial ownership capped at 19.99%.","Registration statement for resale of exchange shares required within 30 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-201351","json":"https://secwatch.observer/filing/0001193125-25-201351.json","markdown":"https://secwatch.observer/filing/0001193125-25-201351.md","text":"https://secwatch.observer/filing/0001193125-25-201351.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/0001193125-25-201351-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/d947025d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:52:52.927905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c26a7a3cc99fab6ef5ba8aa6d563d9a450e53a2","claim":"Jaguar Health, Inc. issued an aggregate of approximately 951 shares (the \"Preferred Shares\") of Series N Perpetual Preferred Stock of preferred stock to certain investors named therein (collectively, the \"Purchasers\") for aggregate purchase price of approximately $2.38 million.","evidence_excerpt":"Shares”) of Series N Perpetual Preferred Stock, par value $0.0001 per share, of the Company (“Series N Preferred Stock”), for an aggregate purchase price of approximately $2.38 million (the “Private Placement”). The Private Placement closed on September 10, 2025, subject to customary closing conditions as set forth in the PIPE Purchase Agreements. The Company","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/0001193125-25-201351-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"an aggregate of approximately 951 shares (the \"Preferred Shares\") of Series N Perpetual Preferred Stock"},{"label":"Purchaser","value":"certain investors named therein (collectively, the \"Purchasers\")"},{"label":"Consideration","value":"aggregate purchase price of approximately $2.38 million"}],"fact_type":"equity_issuance"},{"claim_id":"2d1c5b99f1f249714c0e63c13b174eaf1dca22a3","claim":"Jaguar Health, Inc.: Filed Series N Certificate of Designation for preferred stock (effective 2025-09-09).","evidence_excerpt":"Series N Certificate of Designation As disclosed under Items 1.01 and 3.02 above, in connection with the Private Placement, the Company agreed to issue shares of Series N Preferred Stock to the Purchasers. The preferences, rights, limitations and other matters relating to the Series N Preferred Stock are set forth in the Certificate of Designation, which the Company filed with the Secretary of State of the State of Delaware on September 9, 2025.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525201351/0001193125-25-201351-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}